Cargando…
Evaluating outcomes of mother–infant pairs using dolutegravir for HIV treatment during pregnancy
OBJECTIVES: Dolutegravir (DTG), a second-generation integrase inhibitor, is an effective treatment for HIV but its safety and efficacy are not well established in pregnancy. Here, we assess maternal and infant outcomes of mother–infant pairs using DTG-containing regimens during pregnancy. METHODS: W...
Autores principales: | Grayhack, Clara, Sheth, Anandi, Kirby, Olivia, Davis, Jennifer, Sibliss, Kedesha, Nkwihoreze, Hervette, Aaron, Erika, Alleyne, Gregg, Laguerre, Roberta, Rana, Aadia, Badell, Martina, Momplaisir, Florence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125741/ https://www.ncbi.nlm.nih.gov/pubmed/29944472 http://dx.doi.org/10.1097/QAD.0000000000001931 |
Ejemplares similares
-
Evaluating Outcomes of Mother-Infant Pairs Using Dolutegravir for Treatment of HIV During Pregnancy
por: Sibliss, Kedesha, et al.
Publicado: (2017) -
Assessing the Acceptability of a Community-Based Intervention to Improve the Continuum of Care of Postpartum Women Living with HIV
por: Akinde, Yetunde, et al.
Publicado: (2017) -
Assessing the Acceptability of a Peer Mentor Mother Intervention to Improve Retention in Care of Postpartum Women Living with HIV
por: Akinde, Yetunde, et al.
Publicado: (2019) -
611. Placental Pathology and Neonatal Outcomes in Pregnancies of Perinatally vs. Nonperinatally HIV-Infected Women
por: Zeineddine, Nabil, et al.
Publicado: (2018) -
Integrating ART adherence support technologies in the care of pregnant and postpartum people with HIV: a qualitative study
por: Rendell, Sara, et al.
Publicado: (2022)